CH
Colin Hislop
Chief Medical Officer

Colin Hislop insider trades: Versartis (VSAR) stock buys and sales

Chief Medical Officer, Versartis Last trade Oct 19, 2017 26 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
7
Open-market trades
since 2010
2
Companies
last trade 2017

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Colin reports to the SEC

Open-market buys and sales

7 trades reported on SEC Form 4, newest first

DateStockTypeValue
Oct 19, 2017VSAR↓ Sell$2K
Apr 4, 2017VSAR↓ Sell10b5-1$742K
Nov 13, 2015ANTH↓ Sell10b5-1$66K
Nov 11, 2015ANTH↓ Sell$27K
Feb 3, 2012ANTH↓ Sell$246K
Nov 8, 2011ANTH↓ Sell$101K
Aug 18, 2010ANTH↑ Buy$2K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About Colin Hislop's insider trades

Colin Hislop is Chief Medical Officer at Versartis (VSAR). Since Aug 18, 2010, Colin has reported 1 open-market purchase worth $2K and 6 sales worth $1.2M on SEC Form 4. There have been no open-market trades in the last 12 months.

2 sales (68% of the value sold) were made under a Rule 10b5-1 trading plan, which is set up months in advance and runs on a schedule, so they say little about how the insider sees the stock today.

Their filings also include grants and awards (13 filings), option exercises (7 filings), shares withheld for taxes (3 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every VSAR insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.